Lightning eMotors (ZEVY) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	8 Months Ended
	Sep. 30, 2020	Nov. 02, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	GigCapital3, Inc.
Entity Central Index Key	0001802749
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		25,893,479
Entity Shell Company	true
Entity File Number	001-39283
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-4605714
Entity Address, Address Line One	1731 Embarcadero Rd.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Palo Alto
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94303
City Area Code	(650)
Local Phone Number	276-7040
Document Quarterly Report	true
Document Transition Report	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Common Stock and three-fourths of one Redeemable Warrant
Trading Symbol	GIK.U
Security Exchange Name	NYSE
Units
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	GIK
Security Exchange Name	NYSE
Warrants
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants, each full warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	GIK.WS
Security Exchange Name	NYSE

Condensed Balance Sheet

Condensed Balance Sheet	Sep. 30, 2020USD ($)
Current Assets
Cash	$ 1,587,093
Prepaid expenses and other current assets	248,274
Receivable from related party	111
Total current assets	1,835,478
Cash and marketable securities held in Trust Account	202,037,099
Interest receivable on cash and marketable securities held in the Trust Account	1,661
Other non-current assets	72,459
TOTAL ASSETS	203,946,697
Current liabilities
Accounts payable	119,462
Payable to related parties	9,376
Accrued liabilities	36,126
Other current liabilities	11,566
Total current liabilities	176,530
Deferred underwriting fee payable	8,000,000
Total liabilities	8,176,530
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 18,888,135 shares, at a redemption value of $10.10 per share	190,770,164
Stockholders’ equity
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 6,977,194 shares issued and outstanding (excluding 18,916,285 shares subject to possible redemption)	701
Additional paid-in capital	5,456,018
Accumulated deficit	(456,716)
Total stockholders’ equity	5,000,003
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ EQUITY	$ 203,946,697

Condensed Balance Sheet (Parent

Condensed Balance Sheet (Parenthetical)	8 Months Ended
	Sep. 30, 2020$ / sharesshares
Common stock subject to possible redemption, shares	18,888,135
Common stock subject to possible redemption value per share | $ / shares	$ 10.10
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	7,005,344
Common stock, shares outstanding	7,005,344
Number of shares forfeited	750,000
Common Stock
Common stock subject to possible redemption, shares	18,888,135
Common stock, shares authorized	100,000,000
Common stock, shares issued	7,005,344
Common stock, shares outstanding	7,005,344
Founders | Common Stock
Number of shares forfeited	750,000

Condensed Statements of Operati

Condensed Statements of Operations and Comprehensive Income Loss (Unaudited) - USD ($)		3 Months Ended	8 Months Ended
		Sep. 30, 2020	Sep. 30, 2020
Income Statement [Abstract]
General and administrative expenses		$ 311,796	$ 483,910
Loss from operations		(311,796)	(483,910)
Other income
Interest income on cash and marketable securities held in Trust Account		17,783	38,760
Loss before provision for income taxes		(294,013)	(445,150)
Provision for income taxes		5,307	11,566
Net loss and comprehensive loss		(299,320)	(456,716)
Net loss attributable to common stockholders		$ (308,421)	$ (476,553)
Weighted-average common shares outstanding, basic and diluted	[1]	6,976,575	5,920,089
Net loss per share common share, basic and diluted		$ (0.04)	$ (0.08)
[1]	This number excludes the 750,000 Founder Shares (as described in Note 4) that were forfeited because the over-allotment option was not exercised by the Underwriters.

Condensed Statements of Opera_2

Condensed Statements of Operations and Comprehensive Income Loss (Parenthetical) (Unaudited)	8 Months Ended
	Sep. 30, 2020shares
Income Statement [Abstract]
Number of shares forfeited	750,000

Condensed Statements of Stockho

Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)		Total	Underwriters in Private Placement	Initial Public Offering	Founders	FoundersPrivate Placement	Common Stock	Common StockUnderwriters in Private Placement	Common StockInitial Public Offering	Common StockFounders	Common StockFoundersPrivate Placement	Additional Paid-in Capital	Additional Paid-in CapitalUnderwriters in Private Placement	Additional Paid-in CapitalInitial Public Offering	Additional Paid-in CapitalFounders	Additional Paid-in CapitalFoundersPrivate Placement	Accumulated Deficit
Balance at Feb. 02, 2020
Balance, Shares at Feb. 02, 2020
Sale of common stock			$ 2,434,790	$ 187,267,093	$ 25,000	$ 6,500,000		$ 24	$ 2,000	$ 574	$ 65		$ 2,434,766	$ 187,265,093	$ 24,426	$ 6,499,935
Sale of common stock, Shares								243,479	20,000,000	5,735,000	650,000
Issuance of common stock to Insiders for no consideration							$ 2					(2)
Issuance of Insider shares for no consideration, Shares		15,000					15,000
Forfeiture of common stock sold to Founder due to over-allotment not being exercised	[1]						$ (75)					75
Forfeiture of common stock sold to Founder due to over-allotment not being exercised, shares	[1]						(750,000)
Shares subject to redemption		$ (190,770,164)					$ (1,889)					(190,768,275)
Shares subject to redemption, Shares							(18,888,135)
Net loss		(456,716)															(456,716)
Balance at Sep. 30, 2020		$ 5,000,003					$ 701					5,456,018					(456,716)
Balance, Shares at Sep. 30, 2020		7,005,344					7,005,344
Balance at Jun. 30, 2020		$ 5,000,008					$ 698					5,156,706					(157,396)
Balance, Shares at Jun. 30, 2020							6,977,194
Reduction to offering costs		15,000										15,000
Shares subject to redemption		284,315					$ 3					284,312
Shares subject to redemption, Shares							28,150
Net loss		(299,320)															(299,320)
Balance at Sep. 30, 2020		$ 5,000,003					$ 701					$ 5,456,018					$ (456,716)
Balance, Shares at Sep. 30, 2020		7,005,344					7,005,344
[1]	750,000 Founder Shares were forfeited because the over-allotment option was not exercised by the Underwriters (see Note 4).

Condensed Statements of Stock_2

Condensed Statements of Stockholders' Equity (Parenthetical) (Unaudited) - $ / shares	3 Months Ended	8 Months Ended
	Jun. 30, 2020	Sep. 30, 2020	Feb. 14, 2020
Number of shares forfeited		750,000
Underwriters in Private Placement
Sale of common stock price per share		$ 10
Founders
Sale of common stock price per share		0.0044
Founders | Private Placement
Sale of common stock price per share		$ 10
Founders | Common Stock
Sale of common stock price per share			$ 0.0044
Number of shares forfeited	750,000	750,000

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows (Unaudited)	8 Months Ended
	Sep. 30, 2020USD ($)
OPERATING ACTIVITIES
Net loss	$ (456,716)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(37,099)
Interest receivable on cash and marketable securities held in Trust Account	(1,661)
Change in operating assets and liabilities:
Prepaid expenses	(248,274)
Receivable from related party	(111)
Other non-current assets	(72,459)
Accounts payable	34,462
Payable to related parties	9,376
Accrued liabilities	36,126
Other current liabilities	11,566
Net cash and cash equivalents used in operating activities	(724,790)
INVESTING ACTIVITIES
Investment of cash in Trust Account	(202,000,000)
Net cash and cash equivalents used in investing activities	(202,000,000)
FINANCING ACTIVITIES
Proceeds from sale of common stock to Founder	25,000
Proceeds from sale of Units, net of underwriting discounts paid	196,000,000
Borrowing from a related party	100,000
Repayment of borrowing from a related party	(100,000)
Payment of deferred offering costs	(647,907)
Net cash and cash equivalents provided by financing activities	204,311,883
Net change in cash and cash equivalents during period	1,587,093
Cash and cash equivalents, end of period	1,587,093
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Offering costs included in accounts payable	85,000
Deferred underwriting fee payable upon business combination	8,000,000
Change in value of common stock subject to possible redemption	3,503,071
Founders
FINANCING ACTIVITIES
Proceeds from sale of Private Placement Units	6,500,000
Underwriters
FINANCING ACTIVITIES
Proceeds from sale of Private Placement Units	$ 2,434,790

Description of Organization and

Description of Organization and Business Operations	8 Months Ended
	Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization and Business Operations	1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Organization and General GigCapital3, Inc. (the “Company”) was incorporated in Delaware on February 3, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of September 30, 2020, the Company had not commenced any operations. All activity for the period from February 3, 2020 (date of inception) through September 30, 2020 relates to the Company’s formation and the initial public offering (the “Offering”), as described in Note 3, and identifying a target Business Combination, as described below. The Company will not generate any operating revenues until after completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Offering. The Company has selected December 31 as its fiscal year end. On May 5, 2020, the registration statement on Form S-1 (the “Registration Statement”), as amended, filed in connection with the Offering was declared effective and amended by the Post-Effective Amendment No. 1 to the Registration Statement, as declared effective by the SEC on May 13, 2020. The Company concurrently entered into an underwriting agreement on May 13, 2020 to conduct the Offering, the closing of which was consummated on May 18, 2020 with the delivery of 20,000,000 units (the “Units”). The Units sold in the Offering consisted of the securities described in Note 3. The Offering generated gross proceeds of $200,000,000. Simultaneously with the closing of the Offering, the Company consummated the closing of a private placement sale (the “Private Placement”) of 893,479 units (the “Private Placement Units”), at a price of $10.00 per Private Placement Unit. The Company’s sponsor, GigAcquisitions3, LLC, a Delaware limited liability company (the “Founder”) purchased 650,000 Private Placement Units and Nomura Securities International, Inc. (“Nomura”), Oppenheimer & Co. Inc. (“Oppenheimer”) and Odeon Capital Group LLC (“Odeon”) (collectively, the “Underwriters”) purchased 243,479 Private Placement Units in the aggregate. The Private Placement Units consisted of the securities described in Note 4. The closing of the Private Placement generated gross proceeds of $8,934,790 consisting of $6,500,000 from the sale of the Private Placement Units to the Founder and $2,434,790 from the sale of Private Placement Units to the Underwriters. Following the closing of the Offering, net proceeds in the amount of $196,000,000 from the sale of the Units and proceeds in the amount of $6,000,000 from the sale of Private Placement Units, for a total of $202,000,000, were placed in a trust account (“Trust Account”), which is described further below. Transaction costs amounted to $12,785,179, consisting of $4,000,000 of underwriting fees, $8,000,000 of deferred underwriting fees and $785,179 of offering costs. The Company’s remaining cash after payment of the offering costs will be held outside of the Trust Account for working capital purposes. Subsequently to the closing of the Offering, offering costs of $785,179 accrued for at the closing of the Offering were reduced to $732,907. Therefore, total transaction costs amounted to $12,732,907. The Trust Account The funds in the Trust Account have been invested only in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government obligations. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Business Combination or (ii) the distribution of the Trust Account as described below. The remaining proceeds from the Offering outside the Trust Account may be used to pay for business, legal and accounting due diligence expenses on acquisition targets and continuing general and administrative expenses. The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of 100% of the shares of common stock included in the units sold in the Offering (the “public shares”) if the Company is unable to complete a Business Combination within 18 months from the closing of the Offering on May 18, 2020; or (iii) the redemption of the public shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if it does not complete its initial Business Combination within 18 months from the closing of the Offering on May 18, 2020. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Offering, although substantially all of the net proceeds of the Offering are intended to be The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable or (ii) provide stockholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to commencement of the tender offer, including interest but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to redeem their shares to the Company in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by New York Stock Exchange rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares and the related Business Combination, and instead may search for an alternate Business Combination. If the Company holds a stockholder vote or there is a tender offer for shares in connection with a Business Combination, a public stockholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable. As a result, such shares of common stock have been recorded at their redemption amount and classified as temporary equity. The amount held in the Trust Account as of September 30, 2020 was $202,037,099, which represents cash and marketable securities of $202,000,000 from the sale of 20,000,000 Units at $10.00 per public share, net of underwriting fees of $4,000,000, the sale of 243,479 Private Placement Units to the Underwriters at $10.00 per Private Placement Unit, the sale of 650,000 Private Placement Units at $10.00 per Private Placement Unit, net of cash reserved for operating needs of the Company, and $37,099 of interest income earned on these holdings. Additionally, there was $1,661 of interest accrued, but not yet credited to the Trust Account, which was recorded in the condensed balance sheet in interest receivable on cash and marketable securities held in the Trust Account as of September 30, 2020. The Company will have 18 months from May 18, 2020, the closing date of the Offering, to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest, but less taxes payable (less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining stockholders, as part of its plan of dissolution and liquidation. The Founder, the Underwriters, and Messrs. Weightman, Wang and Betti-Berutto (the “Insiders”) have entered into letter agreements with the Company, pursuant to which they have agreed to waive their rights to participate in any redemption with respect to their initial shares; however, if the Founder, the Underwriters, the Insiders or any of the Company’s officers, directors or affiliates acquired shares of common stock after the Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit.

Summary of Significant Accounti

Summary of Significant Accounting Policies	8 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020, and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company's final prospectus dated May 13, 2020, as well as the Company’s current report on Form 8-K filed with the SEC on May 26, 2020. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods. Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised accounting standard at the time private companies adopt the new or revised standard. Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating the net loss per common share. Shares of common stock subject to possible redemption as of September 30, 2020 have been excluded from the calculation of the basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. When calculating its diluted net loss per share, the Company has not considered the effect of (i) the incremental number of shares of common stock to settle warrants sold in the Offering and Private Placement, as calculated using the treasury stock method; (ii) the shares issued to the Insiders representing 15,000 shares of common stock underlying restricted stock awards for the periods they were outstanding; and (iii) the 750,000 shares of common stock issued to the Founder that were forfeited due to the over-allotment option not being exercised by the Underwriters. Since the Company was in a net loss position during the periods after deducting net income attributable to common stock subject to redemption, diluted net loss per common share is the same as basic net loss per common share for the periods presented as the inclusion of all potential common shares outstanding would have been anti-dilutive. Reconciliation of Net Loss Per Common Share In accordance with the two-class method, the Company’s net loss is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 Period from February 3, 2020 (Inception) through September 30, 2020 Net loss $ (299,320 ) $ (456,716 ) Less: net income attributable to common stock subject to redemption (9,101 ) (19,837 ) Net loss attributable to common stockholders $ (308,421 ) $ (476,553 ) Weighted-average common shares outstanding, basic and diluted 6,976,575 5,920,089 Net loss per share common share, basic and diluted $ (0.04 ) $ (0.08 ) Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions. Cash and Marketable Securities Held in Trust Account As of September 30, 2020, the assets held in the Trust Account consisted of money market funds and cash. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the condensed balance sheets primarily due to their short-term nature. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Offering Costs Offering costs in the amount of $12,732,907 consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Offering. Offering costs were charged to stockholders’ equity and recorded in additional paid-in capital as a reduction to the gross proceeds received upon completion of the Offering. Common Stock Subject to Possible Redemption Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2020, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet. Stock-based Compensation Stock-based compensation related to restricted stock awards are based on fair value of common stock on the grant date. The shares underlying the Company’s restricted stock awards are subject to forfeiture if these individuals resign or are terminated for cause prior to the completion of the Business Combination. Therefore, the related stock-based compensation will be recognized upon the completion of a Business Combination, unless the related shares are forfeited prior to a Business Combination occurring. Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements The Company does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Offering

Offering	8 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Offering	3. OFFERING On May 18, 2020, the Company completed the closing of the Offering whereby the Company sold 20,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of the Company’s common stock, $0.0001 par value (“Common Stock”), and three-fourths (3/4) of one redeemable warrant (a “Public Warrant”). per full share. Under the terms of the warrant agreement (the “Warrant Agreement”), the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the Company’s Business Combination. N o As previously reported on a Form S-1/A of the Company, on April 22, 2020, the Company entered into an Amended and Restated Subscription Agreement for Founder Shares, dated April 16, 2020 (the “Subscription Agreement”), by and between the Company and the Founder, pursuant to which the Founder agreed to acquire 5,735,000 shares of the Common Stock, of the Company, including up to 750,000 Founder Shares that Founder agreed to surrender and have cancelled in the event that the Underwriters did not fully exercise the underwriter over-allotment option. The Underwriters had 45 days from May 13, 2020 to exercise their over-allotment option, which period expired on June 27, 2020. As a result of the Underwriters not exercising their over-allotment option by June 27, 2020, the Founder was obligated, pursuant to the terms of the Subscription Agreement, to surrender and cancel all of the 750,000 Founder Shares held by it that it agreed in the Subscription Agreement to surrender and have cancelled in the event that the Underwriters did not exercise such over-allotment option. Such surrender and cancellation occurred on June 29, 2020 as described in the Company’s Form 8-K filed with the SEC on June 30, 2020. On June 29, 2020, the Company announced that the holders of the Company’s Units may elect to separately trade the securities underlying such Units which commenced on July 2, 2020. Any Units not separated will continue to trade on the New York Stock Exchange under the symbol “GIK.U”. Any underlying shares of Common Stock and warrants that are separated will trade on the New York Stock Exchange under the symbols “GIK,” and “GIK. WS”, respectively.

Related Party Transactions

Related Party Transactions	8 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	4. RELATED PARTY TRANSACTIONS Founder Shares During the period from February 3, 2020 (date of inception) to February 14, 2020, the Founder purchased 5,735,000 shares of Common Stock (the “Founder Shares”) for an aggregate purchase price of $25 , 000, or $0 . 0044 per share. The Company also issued 5,000 shares of Common Stock, solely in consideration of future services, to each of the Insiders pursuant to Insider Shares Grant Agreements dated May 13, 2020 between the Company and each of the Insiders, for an aggregate issuance of 15,000 shares of Common Stock (the “Insider Shares”). The Insider Shares are subject to forfeiture if the individuals resign or the services are terminated for cause prior to the completion of the Business Combination. The Founder Shares a re identical to the Common Stock included in the Units being sold in the Offering except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below. The Founder has forfeited 750 , 000 Founder Share s because the over-allotment option was not exercised by the Underwriters . Because the entire over-allotment option was not exercised, the forfeiture did not need to be adjusted. Therefore, the Founder and Insiders collectively own approximately 22% of the Company’s issued and outstanding shares after the Offering, the Private Placement, and forfeiture of 750,000 Founder Shares. Private Placement The Founder and the Underwriters purchased from the Company an aggregate of 650,000 and 243,479 Private Placement Units, respectively, at a price of $10.00 per unit in a private placement that occurred simultaneously with the completion of the closing of the Offering. Each Private Placement Unit consists of one share of the Company’s Common Stock , and three-fourths (3/4) of one warrant (a “Private Placement Warrant”) . Warrant will be exercisable for $11.50 per share, and the exercise price of the Private Placement Warrants may be adjusted in certain circumstances as described in Note 6 . No fractional shares will be issued upon exercise of the Private Placement Warrants. If, upon exercise of the Private Placement Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Private Placement Warrant holder. Each Private Placement Warrant will become exercisable on the later of 30 days after the completion of the Company’s Business Combination or 12 months from the closing of the Offering and will expire five years after the completion of the Company’s Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete a Business Combination on or prior to the 18-month period allotted to complete the Business Combination, the Private Placement Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Common Stock to the holder upon exercise of the Private Placement Warrants during the exercise period, there will be no net cash settlement of these Private Placement Warrants and the Private Placement Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the Warrant Agreement. Once the Private Placement Warrants become exercisable, the Company may redeem the outstanding Private Placement Warrants in whole and not in part at a price of $0.01 per Private Placement Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of Common Stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Private Placement Warrant holders. The Company’s Founder, Insiders and Underwriters have agreed not to transfer, assign or sell any of their respective Founder Shares, shares held by the Insiders, Private Placement Units, shares or other securities underlying such Private Placement Units that they may hold until the date that is (i) in the case of the Founder Shares or shares held by the Insiders, the earlier of (A) 12 months after the date of the consummation of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) the date on which the last sale price of the Company’s Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the Company’s Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other property, and (ii) in the case of the Private Placement Units and shares or other securities underlying such Private Placement Units, until 30 days after the completion of the Company’s Business Combination. Unlike the Public Warrants included in the Units sold in the Offering, if held by the original holder or its permitted transferees, the warrants included in the Private Placement Units are not redeemable by the Company and subject to certain limited exceptions, will be subject to transfer restrictions until one year following the consummation of the Business Combination. If the warrants included in the Private Placement Units are held by holders other than the initial holders or their permitted transferees, the warrants included in the Private Placement Units will be redeemable by the Company and exercisable by holders on the same basis as the warrants included in the Offering. If the Company does not complete a Business Combination, then a portion of the proceeds from the sale of the Private Placement Units will be part of the liquidating distribution to the public stockholders. Administrative Services Agreement and Other Agreements The Company agreed to pay $20,000 a month for office space, administrative services and secretarial support to an affiliate of the Founder, GigFounders, LLC. Services commenced on May 14, 2020, the date the securities were first listed on the New York Stock Exchange, and will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company.

Commitments and Contingencies

Commitments and Contingencies	8 Months Ended
	Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	5. COMMITMENTS AND CONTINGENCIES Registration Rights On May 13, 2020, the Company entered into a Registration Rights Agreement with its Founder, the Underwriters and Insiders. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. There will be no penalties associated with delays in registering the securities under the Registration Rights Agreement. Underwriters Agreement The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover any over-allotments, at the Offering price less underwriting discounts and commissions. On June 27, 2020, the over-allotment option expired and the Underwriters did not exercise the option as described in Note 3. The Company paid an underwriting discount of $0.20 per Unit to the Underwriters at the closing of the Offering. The underwriting discount was paid in cash. In addition, the Company has agreed to pay deferred underwriting commissions of $0.40 per Unit, or $8,000,000 in the aggregate. The deferred underwriting commission will become payable to the Underwriters from the amount held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, including the performance of services described below. As further described in Note 4, the Underwriters have purchased 243,479 Private Placement Units, of which each Private Placement Unit consists of one share of the Company’s Common Stock , and three-fourths (3/4) of one Private Placement Warrant The Underwriters will use their commercially reasonable efforts to provide the Company with the following services: 1) originating and introducing the Company to potential targets for a Business Combination; 2) arranging institutional investor meetings on the Company’s behalf in connection with obtaining financing for the Business Combination; 3) assisting the Company in meeting its securities exchange listing requirements following the closing of the Offering; and 4) providing capital markets advice and liquidity to the Company following the closing of the Offering. If the Company uses its best efforts (and the Underwriters use commercially reasonable efforts) to obtain financing in private placements or privately negotiated transactions, but notwithstanding such efforts, the Company does not have sufficient cash necessary to consummate the Business Combination and pay the deferred underwriting commission, the Company and the Underwriters will cooperate in good faith to come to a mutually-satisfactory solution with respect to the payment of the deferred underwriting commission so as to ensure that the Company’s obligation to pay the deferred underwriting commission shall not impede the closing of the Business Combination. Related Party Loan The Company entered into a promissory note agreement with the Founder under which $100,000 was loaned to the Company for the payment of expenses related to the Offering. The promissory note was non-interest bearing, unsecured and was repaid in full on May 18, 2020.

Stockholders' Equity

Stockholders' Equity	8 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity	6. STOCKHOLDERS’ EQUITY Common Stock The authorized Common Stock of the Company includes up to 100,000,000 shares. Holders of the Company’s Common Stock are entitled to one vote for each share of Common Stock. As of September 30, 2020, there were 7,005,344 shares of Common Stock issued and outstanding and not subject to possible redemption. There were 18,888,135 shares of Common Stock subject to possible redemption issued and outstanding as of September 30, 2020. Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. As of September 30, 2020, there were no shares of preferred stock issued and outstanding. Warrants (Public Warrants and Private Placement Warrants) Warrants will be exercisable for $11.50 per share, and the exercise price and number of Warrant shares issuable on exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation of the Company. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s Board of Directors, and in the case of any such issuance to the Company’s Founder or its affiliates, without taking into account any Founder Shares held by it prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 65% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading-day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities. Each Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption. However, if the Company does not complete its initial Business Combination on or prior to the 18-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Common Stock to the holder upon exercise of the Warrants during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the Warrant Agreement. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of Common Stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Warrant holders. Under the terms of the Warrant Agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the Company’s initial Business Combination, for the registration of the shares of Common Stock issuable upon exercise of the Warrants included in the Units and Private Placement Units. As of September 30, 2020, there were 15,670,104 Warrants outstanding. Stock-based Compensation Also included in the outstanding shares of Common Stock are 15,000 shares issued in consideration of future services to the Insiders, who are non-employee consultants. These shares are subject to forfeiture if the individuals resign or are terminated for cause prior to the completion of the Business Combination. If an initial Business Combination occurs and these shares have not been previously forfeited, the fair value of the Common Stock on the date the shares vest will be recognized as stock-based compensation in the Company’s statements of operations and comprehensive income when the completion of the Business Combination becomes probable.

Fair Value Measurements

Fair Value Measurements	8 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs which are supported by little or no market activity and which are significant to the fair value of the assets or liabilities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level September 30, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 202,037,099 The marketable securities held in the Trust Account are considered trading securities as they are generally used with the objective of generating profits on short-term differences in price and therefore, the realized and unrealized gain and loss are recorded in the condensed statements of operations and comprehensive loss for the periods presented. Additionally, there was $1,661 of interest accrued, but not yet credited to the Trust Account, which was recorded in the condensed balance sheet in interest receivable on cash and marketable securities held in the Trust Account as of September 30, 2020.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	8 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020, and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company's final prospectus dated May 13, 2020, as well as the Company’s current report on Form 8-K filed with the SEC on May 26, 2020. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.
Emerging Growth Company	Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised accounting standard at the time private companies adopt the new or revised standard.
Net Loss Per Share of Common Stock	Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating the net loss per common share. Shares of common stock subject to possible redemption as of September 30, 2020 have been excluded from the calculation of the basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. When calculating its diluted net loss per share, the Company has not considered the effect of (i) the incremental number of shares of common stock to settle warrants sold in the Offering and Private Placement, as calculated using the treasury stock method; (ii) the shares issued to the Insiders representing 15,000 shares of common stock underlying restricted stock awards for the periods they were outstanding; and (iii) the 750,000 shares of common stock issued to the Founder that were forfeited due to the over-allotment option not being exercised by the Underwriters. Since the Company was in a net loss position during the periods after deducting net income attributable to common stock subject to redemption, diluted net loss per common share is the same as basic net loss per common share for the periods presented as the inclusion of all potential common shares outstanding would have been anti-dilutive. Reconciliation of Net Loss Per Common Share In accordance with the two-class method, the Company’s net loss is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 Period from February 3, 2020 (Inception) through September 30, 2020 Net loss $ (299,320 ) $ (456,716 ) Less: net income attributable to common stock subject to redemption (9,101 ) (19,837 ) Net loss attributable to common stockholders $ (308,421 ) $ (476,553 ) Weighted-average common shares outstanding, basic and diluted 6,976,575 5,920,089 Net loss per share common share, basic and diluted $ (0.04 ) $ (0.08 )
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account As of September 30, 2020, the assets held in the Trust Account consisted of money market funds and cash.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the condensed balance sheets primarily due to their short-term nature.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Offering Costs	Offering Costs Offering costs in the amount of $12,732,907 consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Offering. Offering costs were charged to stockholders’ equity and recorded in additional paid-in capital as a reduction to the gross proceeds received upon completion of the Offering.
Common Stock Subject To Possible Redemption	Common Stock Subject to Possible Redemption Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2020, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet.
Stock-based Payment Arrangement	Stock-based Compensation Stock-based compensation related to restricted stock awards are based on fair value of common stock on the grant date. The shares underlying the Company’s restricted stock awards are subject to forfeiture if these individuals resign or are terminated for cause prior to the completion of the Business Combination. Therefore, the related stock-based compensation will be recognized upon the completion of a Business Combination, unless the related shares are forfeited prior to a Business Combination occurring.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Recent Accounting Pronouncements	Recent Accounting Pronouncements

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	8 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Net Loss per Common Share, Basic and Diluted	In accordance with the two-class method, the Company’s net loss is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 Period from February 3, 2020 (Inception) through September 30, 2020 Net loss $ (299,320 ) $ (456,716 ) Less: net income attributable to common stock subject to redemption (9,101 ) (19,837 ) Net loss attributable to common stockholders $ (308,421 ) $ (476,553 ) Weighted-average common shares outstanding, basic and diluted 6,976,575 5,920,089 Net loss per share common share, basic and diluted $ (0.04 ) $ (0.08 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	8 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Summary of Assets Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level September 30, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 202,037,099

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Details) - USD ($)	May 18, 2020	Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Date of incorporation		Feb. 3, 2020
Sale of units		20,000,000
Sale of stock price per unit	$ 10	$ 10
Net proceeds from sale of units in initial public offering		$ 196,000,000
Amount held in trust account		202,037,099
Transaction costs	$ 12,785,179	647,907
Deferred underwriting fees	8,000,000
Original offering cost	785,179
Actual offering costs deferred	732,907
Total transaction costs	$ 12,732,907	$ 12,732,907
Decommissioning trust assets description		The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of 100% of the shares of common stock included in the units sold in the Offering (the “public shares”) if the Company is unable to complete a Business Combination within 18 months from the closing of the Offering on May 18, 2020; or (iii) the redemption of the public shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if it does not complete its initial Business Combination within 18 months from the closing of the Offering on May 18, 2020
Common stock redemption percentage	100.00%
Public shares redemption percentage	100.00%
Minimum percentage of fair market value of business acquisition to trust account balance		80.00%
Amount held in the trust account		$ 202,037,099
Cash and short-term investments		202,000,000
Interest income earned		37,099
Interest receivable on cash and marketable securities held in the Trust Account		1,661
Minimum
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Net tangible assets		5,000,001
Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Net interest to pay dissolution expenses		100,000
Founders
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Proceeds from sale of units or stock		25,000
Proceeds from sale of units in private placement		6,500,000
Initial Public Offering
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units	20,000,000
Gross proceeds from issuance of unit	$ 200,000,000
Proceeds from sale of units or stock		$ 187,267,093
Net proceeds from sale of units in initial public offering	$ 196,000,000
Private Placement
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of stock price per unit	$ 10	$ 10
Gross proceeds from issuance of unit	$ 8,934,790
Proceeds from sale of units in private placement	6,000,000
Amount held in trust account	$ 202,000,000
Sale of units in private placement		650,000
Private Placement | Nomura, Oppenheimer and Odeon
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units	243,479
Proceeds from sale of units or stock	$ 2,434,790
Private Placement | Founders
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units	650,000	650,000
Sale of units in private placement	893,479
Sale of stock price per unit		$ 10
Proceeds from sale of units or stock	$ 6,500,000	$ 6,500,000
Underwriters
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of stock price per unit		$ 10
Transaction costs	$ 4,000,000	$ 4,000,000
Sale of units in private placement		243,479

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	May 18, 2020	Jun. 30, 2020	Sep. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Issuance of Insider shares for no consideration, Shares			15,000
Number of shares forfeited			750,000
Offering costs charged to stockholders' equity upon completion of offering	$ 12,732,907		$ 12,732,907
Unrecognized tax benefits			0
Amount accrued for payment of interest and penalties			$ 0
Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Issuance of Insider shares for no consideration, Shares			15,000
Founders | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares forfeited		750,000	750,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Net Loss per Common Share, Basic and Diluted (Details) - USD ($)		3 Months Ended	8 Months Ended
		Sep. 30, 2020	Sep. 30, 2020
Earnings Per Share [Abstract]
Net loss		$ (299,320)	$ (456,716)
Less: net income attributable to common stock subject to redemption		(9,101)	(19,837)
Net loss attributable to common stockholders		$ (308,421)	$ (476,553)
Weighted-average common shares outstanding, basic and diluted	[1]	6,976,575	5,920,089
Net loss per share common share, basic and diluted		$ (0.04)	$ (0.08)
[1]	This number excludes the 750,000 Founder Shares (as described in Note 4) that were forfeited because the over-allotment option was not exercised by the Underwriters.

Offering - Additional Informati

Offering - Additional Information (Details) - USD ($)	May 18, 2020	Apr. 22, 2020	Sep. 30, 2020
Class Of Stock [Line Items]
Sale of common stock, Shares	20,000,000
Sale of stock price per unit	$ 10		$ 10
Number of shares of common stock per unit	1
Common stock, par value	$ 0.0001		$ 0.0001
Number of public warrants to be exercised in order to obtain whole shares of common stock	4
Exercise price of warrants	$ 11.50
Common stock, shares issued			7,005,344
Underwriters description			The Underwriters had 45 days from May 13, 2020 to exercise their over-allotment option, which period expired on June 27, 2020. As a result of the Underwriters not exercising their over-allotment option by June 27, 2020, the Founder was obligated, pursuant to the terms of the Subscription Agreement, to surrender and cancel all of the 750,000 Founder Shares held by it that it agreed in the Subscription Agreement to surrender and have cancelled in the event that the Underwriters did not exercise such over-allotment option. Such surrender and cancellation occurred on June 29, 2020 as described in the Company’s Form 8-K filed with the SEC on June 30, 2020.
Warrants
Class Of Stock [Line Items]
Sale of units description	Each Unit consists of one share of the Company’s common stock, $0.0001 par value (“Common Stock”), and three-fourths (3/4) of one redeemable warrant (a “Public Warrant”).
Exercise price of warrants			$ 11.50
Number of fractional shares issued upon exercise of warrants			0
Period after business combination when warrants become exercisable			30 days
Period after offering when warrants become exercisable			12 months
Warrants exercisable expiration period after completion of business combination			5 years
Period allotted to complete the business combination			18 months
Net cash settlement value of warrants			$ 0
Redemption price per warrant			$ 0.01
Minimum period of prior written notice of redemption of warrants			30 days
Minimum price per share required for redemption of warrants			$ 18
Warrants redemption covenant, threshold trading days			20 days
Warrants redemption covenant, threshold consecutive trading days			30 days
Warrants | Maximum [Member]
Class Of Stock [Line Items]
Exercise price of warrants			$ 9.20
Subscription Agreement
Class Of Stock [Line Items]
Subscription agreement date		Apr. 16, 2020
Common stock, shares issued		5,735,000
Subscription Agreement | Maximum [Member] | Founders | Underwriters
Class Of Stock [Line Items]
Number of shares forfeited, unexercised by underwriters		750,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	May 18, 2020	May 13, 2020	Feb. 14, 2020	Jun. 30, 2020	Sep. 30, 2020
Related Party Transaction [Line Items]
Sale of common stock, Shares	20,000,000
Proceeds from sale of common stock to Founder					$ 25,000
Number of shares forfeited					750,000
Sale of units					20,000,000
Sale of stock price per unit	$ 10				$ 10
Number of shares of common stock per unit	1
Exercise price of warrants	$ 11.50
Holding period of shares for completion of initial business combination					12 months
Number of trading period for transfer of shares					20 days
Number of consecutive trading period for transfer of shares					30 days
Period after completion of business combination to allow transfer of shares					30 days
Warrants transfer restrictions period following consummation of business combination					1 year
Maximum [Member]
Related Party Transaction [Line Items]
Period after initial business combination to allow transfer of shares					90 days
Private Placement
Related Party Transaction [Line Items]
Sale of stock price per unit	$ 10				$ 10
Insider Shares Grant Agreements
Related Party Transaction [Line Items]
Common stock issued in consideration for future service		5,000			15,000
Grant agreement date					May 13, 2020
Common Stock
Related Party Transaction [Line Items]
Stock price threshold that allows transfer of shares					$ 12.50
Common Stock | Maximum [Member]
Related Party Transaction [Line Items]
Exercise price of warrants					9.20
Warrants
Related Party Transaction [Line Items]
Sale of units description	Each Unit consists of one share of the Company’s common stock, $0.0001 par value (“Common Stock”), and three-fourths (3/4) of one redeemable warrant (a “Public Warrant”).
Exercise price of warrants					$ 11.50
Number of fractional shares issued upon exercise of warrants					0
Period after business combination when warrants become exercisable					30 days
Period after offering when warrants become exercisable					12 months
Warrants exercisable expiration period after completion of business combination					5 years
Period allotted to complete the business combination					18 months
Net cash settlement value of warrants					$ 0
Redemption price per warrant					$ 0.01
Minimum period of prior written notice of redemption of warrants					30 days
Minimum price per share required for redemption of warrants					$ 18
Warrants redemption covenant, threshold trading days					20 days
Warrants redemption covenant, threshold consecutive trading days					30 days
Warrants | Maximum [Member]
Related Party Transaction [Line Items]
Exercise price of warrants					$ 9.20
Founders
Related Party Transaction [Line Items]
Sale of common stock price per share					0.0044
Founders | Private Placement
Related Party Transaction [Line Items]
Sale of common stock price per share					$ 10
Sale of units	650,000				650,000
Sale of stock price per unit					$ 10
Founders | Insider Shares Grant Agreements
Related Party Transaction [Line Items]
Collectively owned of issued and outstanding shares after offering					22.00%
Founders | Common Stock
Related Party Transaction [Line Items]
Sale of common stock, Shares			5,735,000		5,735,000
Proceeds from sale of common stock to Founder			$ 25,000
Sale of common stock price per share			$ 0.0044
Number of shares forfeited				750,000	750,000
Founders | Common Stock | Private Placement
Related Party Transaction [Line Items]
Sale of common stock, Shares					650,000
Underwriters | Private Placement
Related Party Transaction [Line Items]
Sale of units					243,479
Sale of stock price per unit					$ 10
Founder and Underwriters | Private Placement
Related Party Transaction [Line Items]
Number of shares of common stock per unit					1
Sale of units description					Each Private Placement Unit consists of one share of the Company’s Common Stock, and three-fourths (3/4) of one warrant (a “Private Placement Warrant”).
Exercise price of warrants					$ 11.50
Founder and Underwriters | Warrants | Private Placement
Related Party Transaction [Line Items]
Number of fractional shares issued upon exercise of warrants					0
Period after business combination when warrants become exercisable					30 days
Period after offering when warrants become exercisable					12 months
Warrants exercisable expiration period after completion of business combination					5 years
Net cash settlement value of warrants					$ 0
Redemption price per warrant					$ 0.01
Minimum period of prior written notice of redemption of warrants					30 days
Minimum price per share required for redemption of warrants					$ 18
Warrants redemption covenant, threshold trading days					20 days
Warrants redemption covenant, threshold consecutive trading days					30 days
Founder and Underwriters | Warrants | Private Placement | Maximum [Member]
Related Party Transaction [Line Items]
Period allotted to complete the business combination					18 months
GigFounders, LLC | Office Space, Administrative Services and Secretarial Support
Related Party Transaction [Line Items]
Payment to affiliate of sponsor					$ 20,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	May 18, 2020	May 18, 2020	Sep. 30, 2020	Sep. 30, 2020
Other Commitments [Line Items]
Underwriters option period				45 days
Paid an underwriting discount in cash				$ 0.20
Deferred underwriting commissions per unit				$ 0.40
Aggregate deferred underwriting commissions			$ 8,000,000	$ 8,000,000
Aggregate number of shares issued	20,000,000
Number of shares of common stock per unit	1	1
Repayment of promissory notes to related party				$ 100,000
Founders | Promissory Note
Other Commitments [Line Items]
Repayment of promissory notes to related party		$ 100,000
Repayment of promissory notes			The promissory note was non-interest bearing, unsecured and was repaid in full on May 18, 2020.
Underwriters
Other Commitments [Line Items]
Option to purchase additional units to cover over-allotments				3,000,000
Over-allotment option, expiration date				Jun. 27, 2020
Aggregate purchase price				$ 2,434,790
Underwriters | Private Placement
Other Commitments [Line Items]
Aggregate number of shares issued				243,479
Aggregate purchase price				$ 2,434,790
Underwriters | Private Placement | Common Stock
Other Commitments [Line Items]
Number of shares of common stock per unit			1	1
Underwriters | Private Placement | Warrants
Other Commitments [Line Items]
Number of warrant of common stock per unit			0.75	0.75

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($)	8 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	May 18, 2020	Feb. 02, 2020
Class Of Stock [Line Items]
Common stock, shares authorized	100,000,000
Common stock, shares issued	7,005,344
Common stock, shares outstanding	7,005,344
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Exercise price of warrants			$ 11.50
Non-Employee Consultants | Restricted Stock
Class Of Stock [Line Items]
Number of shares subject to forfeiture	15,000
Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized	100,000,000
Common stock, voting rights per share	Holders of the Company’s Common Stock are entitled to one vote for each share of Common Stock.
Common stock, shares issued	7,005,344
Common stock, shares outstanding	7,005,344	6,977,194
Shares subject to possible redemption	18,888,135
Common Stock | Maximum [Member]
Class Of Stock [Line Items]
Exercise price of warrants	$ 9.20
Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Warrants
Class Of Stock [Line Items]
Exercise price of warrants	$ 11.50
Percentage of warrants exercise price	115.00%
Period after business combination when warrants become exercisable	30 days
Period after offering when warrants become exercisable	12 months
Warrants exercisable expiration period after completion of business combination	5 years
Period allotted to complete the business combination	18 months
Net cash settlement value of warrants	$ 0
Redemption price per warrant	$ 0.01
Minimum period of prior written notice of redemption of warrants	30 days
Minimum price per share required for redemption of warrants	$ 18
Warrants redemption covenant, threshold trading days	20 days
Warrants redemption covenant, threshold consecutive trading days	30 days
Warrants or rights outstanding	15,670,104
Warrants | Maximum [Member]
Class Of Stock [Line Items]
Exercise price of warrants	$ 9.20
Warrants | Minimum
Class Of Stock [Line Items]
Percentage of aggregate gross proceeds of equity issuances	65.00%

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Details)	Sep. 30, 2020USD ($)
Assets:
Cash and marketable securities held in Trust Account	$ 202,037,099
Level 1
Assets:
Cash and marketable securities held in Trust Account	$ 202,037,099

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Sep. 30, 2020USD ($)
Fair Value Disclosures [Abstract]
Interest receivable on cash and marketable securities held in the Trust Account	$ 1,661